Atrial Fibrosis Helps Select the Appropriate Patient and Strategy in Catheter Ablation of Atrial Fibrillation: A DE-MRI Guided Approach
MRI for AF Patient Selection and Ablation Approach. Introduction: Left atrial (LA) fibrosis and ablation related scarring are major predictors of success in rhythm control of atrial fibrillation (AF). We used delayed enhancement MRI (DE‐MRI) to stratify AF patients based on pre‐ablation fibrosis and...
Gespeichert in:
Veröffentlicht in: | Journal of cardiovascular electrophysiology 2011-01, Vol.22 (1), p.16-22 |
---|---|
Hauptverfasser: | , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 22 |
---|---|
container_issue | 1 |
container_start_page | 16 |
container_title | Journal of cardiovascular electrophysiology |
container_volume | 22 |
creator | AKOUM, NAZEM DACCARETT, MARCOS MCGANN, CHRIS SEGERSON, NATHAN VERGARA, GASTON KUPPAHALLY, SUMAN BADGER, TROY BURGON, NATHAN HASLAM, THOMAS KHOLMOVSKI, EUGENE MACLEOD, ROB MARROUCHE, NASSIR |
description | MRI for AF Patient Selection and Ablation Approach. Introduction: Left atrial (LA) fibrosis and ablation related scarring are major predictors of success in rhythm control of atrial fibrillation (AF). We used delayed enhancement MRI (DE‐MRI) to stratify AF patients based on pre‐ablation fibrosis and also to evaluate ablation‐induced scarring in order to identify predictors of a successful ablation.
Methods and Results:
One hundred and forty‐four patients were staged by percent of fibrosis quantified with DE‐MRI, relative to the LA wall volume: minimal or Utah stage 1; 35%. All patients underwent pulmonary vein (PV) isolation and posterior wall and septal debulking. Overall, LA scarring was quantified and PV antra were evaluated for circumferential scarring 3 months post ablation. LA scarring post ablation was comparable across the 4 stages. Most patients had either no (36.8%) or 1 PV (32.6%) antrum circumferentially scarred. Forty‐two patients (29%) had recurrent AF over 283 ± 167 days. No recurrences were noted in Utah stage 1. Recurrence was 28% in Utah stage 2, 35% in Utah stage 3, and 56% in Utah stage 4. Recurrence was predicted by circumferential PV scarring in Utah stage 2 and by overall LA wall scarring in Utah stage 3. No recurrence predictors were identified in Utah stage 4.
Conclusions:
Circumferential PV antral scarring predicts ablation success in mild LA fibrosis, while posterior wall and septal scarring is needed for moderate fibrosis. This may help select the proper candidate and strategy in catheter ablation of AF. (J Cardiovasc Electrophysiol, Vol. 22, pp. 16‐22, January 2011) |
doi_str_mv | 10.1111/j.1540-8167.2010.01876.x |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3133570</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>843412829</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5776-bb067a106677d7da52425880ab742805e68335734764615d004bd316480bb36e3</originalsourceid><addsrcrecordid>eNqNkd9u0zAUxiMEYmPwCsh3XKUcx3-HBFIW2m5oYxMDjTvLSdzVJU2C7UL7BLw2zrJV4w7f2Drn-3728ZckCMMEx_V2NcGMQioxF5MMYhWwFHyyfZIc7htP4xkoS4kU5CB54f0KABMO7HlykIEEkQl8mPzJg7O6QTNbus5bj05N03t0bRpTBRSWBuV977o-ioJBVzpY0wak2xpdBxdLtztkW1ToqAzGobxsoqRrUbdAj8i2GcvvUI4-TtOLL2dovrG1qUe6rpYvk2cL3Xjz6n4_Sr7Npl-L0_T8cn5W5OdpxYTgaVkCFxoD50LUotYsoxmTEnQpaCaBGS4JYYJQwSnHrAagZU0wpxLKknBDjpIPI7fflGtTV3EapxsV51trt1OdturfTmuX6rb7pQgewBABb-4Brvu5MT6otfWViQO2ptt4JSmhOJPZcVTKUVnFn_XOLPa3YFBDjGqlhrTUkJYaYlR3MapttL5-_Mq98SG3KHg_Cn7bxuz-G6w-FdPhFP3p6Lc-mO3er90PxQURTN18nqtjWswuspPv6ob8BQqUumo</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>843412829</pqid></control><display><type>article</type><title>Atrial Fibrosis Helps Select the Appropriate Patient and Strategy in Catheter Ablation of Atrial Fibrillation: A DE-MRI Guided Approach</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><creator>AKOUM, NAZEM ; DACCARETT, MARCOS ; MCGANN, CHRIS ; SEGERSON, NATHAN ; VERGARA, GASTON ; KUPPAHALLY, SUMAN ; BADGER, TROY ; BURGON, NATHAN ; HASLAM, THOMAS ; KHOLMOVSKI, EUGENE ; MACLEOD, ROB ; MARROUCHE, NASSIR</creator><creatorcontrib>AKOUM, NAZEM ; DACCARETT, MARCOS ; MCGANN, CHRIS ; SEGERSON, NATHAN ; VERGARA, GASTON ; KUPPAHALLY, SUMAN ; BADGER, TROY ; BURGON, NATHAN ; HASLAM, THOMAS ; KHOLMOVSKI, EUGENE ; MACLEOD, ROB ; MARROUCHE, NASSIR</creatorcontrib><description>MRI for AF Patient Selection and Ablation Approach. Introduction: Left atrial (LA) fibrosis and ablation related scarring are major predictors of success in rhythm control of atrial fibrillation (AF). We used delayed enhancement MRI (DE‐MRI) to stratify AF patients based on pre‐ablation fibrosis and also to evaluate ablation‐induced scarring in order to identify predictors of a successful ablation.
Methods and Results:
One hundred and forty‐four patients were staged by percent of fibrosis quantified with DE‐MRI, relative to the LA wall volume: minimal or Utah stage 1; <5%, mild or Utah stage 2; 5–20%, moderate or Utah stage 3; 20–35%, and extensive or Utah stage 4; >35%. All patients underwent pulmonary vein (PV) isolation and posterior wall and septal debulking. Overall, LA scarring was quantified and PV antra were evaluated for circumferential scarring 3 months post ablation. LA scarring post ablation was comparable across the 4 stages. Most patients had either no (36.8%) or 1 PV (32.6%) antrum circumferentially scarred. Forty‐two patients (29%) had recurrent AF over 283 ± 167 days. No recurrences were noted in Utah stage 1. Recurrence was 28% in Utah stage 2, 35% in Utah stage 3, and 56% in Utah stage 4. Recurrence was predicted by circumferential PV scarring in Utah stage 2 and by overall LA wall scarring in Utah stage 3. No recurrence predictors were identified in Utah stage 4.
Conclusions:
Circumferential PV antral scarring predicts ablation success in mild LA fibrosis, while posterior wall and septal scarring is needed for moderate fibrosis. This may help select the proper candidate and strategy in catheter ablation of AF. (J Cardiovasc Electrophysiol, Vol. 22, pp. 16‐22, January 2011)</description><identifier>ISSN: 1045-3873</identifier><identifier>EISSN: 1540-8167</identifier><identifier>DOI: 10.1111/j.1540-8167.2010.01876.x</identifier><identifier>PMID: 20807271</identifier><language>eng</language><publisher>Malden, USA: Blackwell Publishing Inc</publisher><subject>atrial fibrillation ; Atrial Fibrillation - diagnosis ; Atrial Fibrillation - epidemiology ; Atrial Fibrillation - surgery ; atrial remodeling ; catheter ablation ; Catheter Ablation - statistics & numerical data ; Comorbidity ; Female ; Fibrosis - diagnosis ; Fibrosis - epidemiology ; Fibrosis - surgery ; Heart Atria - pathology ; Heart Atria - surgery ; Humans ; magnetic resonance imaging ; Magnetic Resonance Imaging - statistics & numerical data ; Male ; Middle Aged ; Patient Selection ; Preoperative Care - statistics & numerical data ; Prevalence ; Prognosis ; Risk Assessment ; Risk Factors ; Surgery, Computer-Assisted - statistics & numerical data ; Utah - epidemiology</subject><ispartof>Journal of cardiovascular electrophysiology, 2011-01, Vol.22 (1), p.16-22</ispartof><rights>2010 Wiley Periodicals, Inc.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5776-bb067a106677d7da52425880ab742805e68335734764615d004bd316480bb36e3</citedby><cites>FETCH-LOGICAL-c5776-bb067a106677d7da52425880ab742805e68335734764615d004bd316480bb36e3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1111%2Fj.1540-8167.2010.01876.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1111%2Fj.1540-8167.2010.01876.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>230,315,781,785,886,1418,27928,27929,45578,45579</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/20807271$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>AKOUM, NAZEM</creatorcontrib><creatorcontrib>DACCARETT, MARCOS</creatorcontrib><creatorcontrib>MCGANN, CHRIS</creatorcontrib><creatorcontrib>SEGERSON, NATHAN</creatorcontrib><creatorcontrib>VERGARA, GASTON</creatorcontrib><creatorcontrib>KUPPAHALLY, SUMAN</creatorcontrib><creatorcontrib>BADGER, TROY</creatorcontrib><creatorcontrib>BURGON, NATHAN</creatorcontrib><creatorcontrib>HASLAM, THOMAS</creatorcontrib><creatorcontrib>KHOLMOVSKI, EUGENE</creatorcontrib><creatorcontrib>MACLEOD, ROB</creatorcontrib><creatorcontrib>MARROUCHE, NASSIR</creatorcontrib><title>Atrial Fibrosis Helps Select the Appropriate Patient and Strategy in Catheter Ablation of Atrial Fibrillation: A DE-MRI Guided Approach</title><title>Journal of cardiovascular electrophysiology</title><addtitle>J Cardiovasc Electrophysiol</addtitle><description>MRI for AF Patient Selection and Ablation Approach. Introduction: Left atrial (LA) fibrosis and ablation related scarring are major predictors of success in rhythm control of atrial fibrillation (AF). We used delayed enhancement MRI (DE‐MRI) to stratify AF patients based on pre‐ablation fibrosis and also to evaluate ablation‐induced scarring in order to identify predictors of a successful ablation.
Methods and Results:
One hundred and forty‐four patients were staged by percent of fibrosis quantified with DE‐MRI, relative to the LA wall volume: minimal or Utah stage 1; <5%, mild or Utah stage 2; 5–20%, moderate or Utah stage 3; 20–35%, and extensive or Utah stage 4; >35%. All patients underwent pulmonary vein (PV) isolation and posterior wall and septal debulking. Overall, LA scarring was quantified and PV antra were evaluated for circumferential scarring 3 months post ablation. LA scarring post ablation was comparable across the 4 stages. Most patients had either no (36.8%) or 1 PV (32.6%) antrum circumferentially scarred. Forty‐two patients (29%) had recurrent AF over 283 ± 167 days. No recurrences were noted in Utah stage 1. Recurrence was 28% in Utah stage 2, 35% in Utah stage 3, and 56% in Utah stage 4. Recurrence was predicted by circumferential PV scarring in Utah stage 2 and by overall LA wall scarring in Utah stage 3. No recurrence predictors were identified in Utah stage 4.
Conclusions:
Circumferential PV antral scarring predicts ablation success in mild LA fibrosis, while posterior wall and septal scarring is needed for moderate fibrosis. This may help select the proper candidate and strategy in catheter ablation of AF. (J Cardiovasc Electrophysiol, Vol. 22, pp. 16‐22, January 2011)</description><subject>atrial fibrillation</subject><subject>Atrial Fibrillation - diagnosis</subject><subject>Atrial Fibrillation - epidemiology</subject><subject>Atrial Fibrillation - surgery</subject><subject>atrial remodeling</subject><subject>catheter ablation</subject><subject>Catheter Ablation - statistics & numerical data</subject><subject>Comorbidity</subject><subject>Female</subject><subject>Fibrosis - diagnosis</subject><subject>Fibrosis - epidemiology</subject><subject>Fibrosis - surgery</subject><subject>Heart Atria - pathology</subject><subject>Heart Atria - surgery</subject><subject>Humans</subject><subject>magnetic resonance imaging</subject><subject>Magnetic Resonance Imaging - statistics & numerical data</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Patient Selection</subject><subject>Preoperative Care - statistics & numerical data</subject><subject>Prevalence</subject><subject>Prognosis</subject><subject>Risk Assessment</subject><subject>Risk Factors</subject><subject>Surgery, Computer-Assisted - statistics & numerical data</subject><subject>Utah - epidemiology</subject><issn>1045-3873</issn><issn>1540-8167</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2011</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkd9u0zAUxiMEYmPwCsh3XKUcx3-HBFIW2m5oYxMDjTvLSdzVJU2C7UL7BLw2zrJV4w7f2Drn-3728ZckCMMEx_V2NcGMQioxF5MMYhWwFHyyfZIc7htP4xkoS4kU5CB54f0KABMO7HlykIEEkQl8mPzJg7O6QTNbus5bj05N03t0bRpTBRSWBuV977o-ioJBVzpY0wak2xpdBxdLtztkW1ToqAzGobxsoqRrUbdAj8i2GcvvUI4-TtOLL2dovrG1qUe6rpYvk2cL3Xjz6n4_Sr7Npl-L0_T8cn5W5OdpxYTgaVkCFxoD50LUotYsoxmTEnQpaCaBGS4JYYJQwSnHrAagZU0wpxLKknBDjpIPI7fflGtTV3EapxsV51trt1OdturfTmuX6rb7pQgewBABb-4Brvu5MT6otfWViQO2ptt4JSmhOJPZcVTKUVnFn_XOLPa3YFBDjGqlhrTUkJYaYlR3MapttL5-_Mq98SG3KHg_Cn7bxuz-G6w-FdPhFP3p6Lc-mO3er90PxQURTN18nqtjWswuspPv6ob8BQqUumo</recordid><startdate>201101</startdate><enddate>201101</enddate><creator>AKOUM, NAZEM</creator><creator>DACCARETT, MARCOS</creator><creator>MCGANN, CHRIS</creator><creator>SEGERSON, NATHAN</creator><creator>VERGARA, GASTON</creator><creator>KUPPAHALLY, SUMAN</creator><creator>BADGER, TROY</creator><creator>BURGON, NATHAN</creator><creator>HASLAM, THOMAS</creator><creator>KHOLMOVSKI, EUGENE</creator><creator>MACLEOD, ROB</creator><creator>MARROUCHE, NASSIR</creator><general>Blackwell Publishing Inc</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>201101</creationdate><title>Atrial Fibrosis Helps Select the Appropriate Patient and Strategy in Catheter Ablation of Atrial Fibrillation: A DE-MRI Guided Approach</title><author>AKOUM, NAZEM ; DACCARETT, MARCOS ; MCGANN, CHRIS ; SEGERSON, NATHAN ; VERGARA, GASTON ; KUPPAHALLY, SUMAN ; BADGER, TROY ; BURGON, NATHAN ; HASLAM, THOMAS ; KHOLMOVSKI, EUGENE ; MACLEOD, ROB ; MARROUCHE, NASSIR</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5776-bb067a106677d7da52425880ab742805e68335734764615d004bd316480bb36e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2011</creationdate><topic>atrial fibrillation</topic><topic>Atrial Fibrillation - diagnosis</topic><topic>Atrial Fibrillation - epidemiology</topic><topic>Atrial Fibrillation - surgery</topic><topic>atrial remodeling</topic><topic>catheter ablation</topic><topic>Catheter Ablation - statistics & numerical data</topic><topic>Comorbidity</topic><topic>Female</topic><topic>Fibrosis - diagnosis</topic><topic>Fibrosis - epidemiology</topic><topic>Fibrosis - surgery</topic><topic>Heart Atria - pathology</topic><topic>Heart Atria - surgery</topic><topic>Humans</topic><topic>magnetic resonance imaging</topic><topic>Magnetic Resonance Imaging - statistics & numerical data</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Patient Selection</topic><topic>Preoperative Care - statistics & numerical data</topic><topic>Prevalence</topic><topic>Prognosis</topic><topic>Risk Assessment</topic><topic>Risk Factors</topic><topic>Surgery, Computer-Assisted - statistics & numerical data</topic><topic>Utah - epidemiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>AKOUM, NAZEM</creatorcontrib><creatorcontrib>DACCARETT, MARCOS</creatorcontrib><creatorcontrib>MCGANN, CHRIS</creatorcontrib><creatorcontrib>SEGERSON, NATHAN</creatorcontrib><creatorcontrib>VERGARA, GASTON</creatorcontrib><creatorcontrib>KUPPAHALLY, SUMAN</creatorcontrib><creatorcontrib>BADGER, TROY</creatorcontrib><creatorcontrib>BURGON, NATHAN</creatorcontrib><creatorcontrib>HASLAM, THOMAS</creatorcontrib><creatorcontrib>KHOLMOVSKI, EUGENE</creatorcontrib><creatorcontrib>MACLEOD, ROB</creatorcontrib><creatorcontrib>MARROUCHE, NASSIR</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Journal of cardiovascular electrophysiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>AKOUM, NAZEM</au><au>DACCARETT, MARCOS</au><au>MCGANN, CHRIS</au><au>SEGERSON, NATHAN</au><au>VERGARA, GASTON</au><au>KUPPAHALLY, SUMAN</au><au>BADGER, TROY</au><au>BURGON, NATHAN</au><au>HASLAM, THOMAS</au><au>KHOLMOVSKI, EUGENE</au><au>MACLEOD, ROB</au><au>MARROUCHE, NASSIR</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Atrial Fibrosis Helps Select the Appropriate Patient and Strategy in Catheter Ablation of Atrial Fibrillation: A DE-MRI Guided Approach</atitle><jtitle>Journal of cardiovascular electrophysiology</jtitle><addtitle>J Cardiovasc Electrophysiol</addtitle><date>2011-01</date><risdate>2011</risdate><volume>22</volume><issue>1</issue><spage>16</spage><epage>22</epage><pages>16-22</pages><issn>1045-3873</issn><eissn>1540-8167</eissn><abstract>MRI for AF Patient Selection and Ablation Approach. Introduction: Left atrial (LA) fibrosis and ablation related scarring are major predictors of success in rhythm control of atrial fibrillation (AF). We used delayed enhancement MRI (DE‐MRI) to stratify AF patients based on pre‐ablation fibrosis and also to evaluate ablation‐induced scarring in order to identify predictors of a successful ablation.
Methods and Results:
One hundred and forty‐four patients were staged by percent of fibrosis quantified with DE‐MRI, relative to the LA wall volume: minimal or Utah stage 1; <5%, mild or Utah stage 2; 5–20%, moderate or Utah stage 3; 20–35%, and extensive or Utah stage 4; >35%. All patients underwent pulmonary vein (PV) isolation and posterior wall and septal debulking. Overall, LA scarring was quantified and PV antra were evaluated for circumferential scarring 3 months post ablation. LA scarring post ablation was comparable across the 4 stages. Most patients had either no (36.8%) or 1 PV (32.6%) antrum circumferentially scarred. Forty‐two patients (29%) had recurrent AF over 283 ± 167 days. No recurrences were noted in Utah stage 1. Recurrence was 28% in Utah stage 2, 35% in Utah stage 3, and 56% in Utah stage 4. Recurrence was predicted by circumferential PV scarring in Utah stage 2 and by overall LA wall scarring in Utah stage 3. No recurrence predictors were identified in Utah stage 4.
Conclusions:
Circumferential PV antral scarring predicts ablation success in mild LA fibrosis, while posterior wall and septal scarring is needed for moderate fibrosis. This may help select the proper candidate and strategy in catheter ablation of AF. (J Cardiovasc Electrophysiol, Vol. 22, pp. 16‐22, January 2011)</abstract><cop>Malden, USA</cop><pub>Blackwell Publishing Inc</pub><pmid>20807271</pmid><doi>10.1111/j.1540-8167.2010.01876.x</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 1045-3873 |
ispartof | Journal of cardiovascular electrophysiology, 2011-01, Vol.22 (1), p.16-22 |
issn | 1045-3873 1540-8167 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_3133570 |
source | MEDLINE; Access via Wiley Online Library |
subjects | atrial fibrillation Atrial Fibrillation - diagnosis Atrial Fibrillation - epidemiology Atrial Fibrillation - surgery atrial remodeling catheter ablation Catheter Ablation - statistics & numerical data Comorbidity Female Fibrosis - diagnosis Fibrosis - epidemiology Fibrosis - surgery Heart Atria - pathology Heart Atria - surgery Humans magnetic resonance imaging Magnetic Resonance Imaging - statistics & numerical data Male Middle Aged Patient Selection Preoperative Care - statistics & numerical data Prevalence Prognosis Risk Assessment Risk Factors Surgery, Computer-Assisted - statistics & numerical data Utah - epidemiology |
title | Atrial Fibrosis Helps Select the Appropriate Patient and Strategy in Catheter Ablation of Atrial Fibrillation: A DE-MRI Guided Approach |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-17T06%3A32%3A30IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Atrial%20Fibrosis%20Helps%20Select%20the%20Appropriate%20Patient%20and%20Strategy%20in%20Catheter%20Ablation%20of%20Atrial%20Fibrillation:%20A%20DE-MRI%20Guided%20Approach&rft.jtitle=Journal%20of%20cardiovascular%20electrophysiology&rft.au=AKOUM,%20NAZEM&rft.date=2011-01&rft.volume=22&rft.issue=1&rft.spage=16&rft.epage=22&rft.pages=16-22&rft.issn=1045-3873&rft.eissn=1540-8167&rft_id=info:doi/10.1111/j.1540-8167.2010.01876.x&rft_dat=%3Cproquest_pubme%3E843412829%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=843412829&rft_id=info:pmid/20807271&rfr_iscdi=true |